Related Experiment Video
Updated: Aug 1, 2025
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Helicobacter pylori and Human Immunodeficiency Virus Co-Infection: Potential Implications for Future Gastric Cancer
Marcel Nkuize1, Stéphane De Wit1, Pieter Demetter2
1Saint Pierre University Hospital Brussels, Université Libre de Bruxelles, 1050 Brussels, Belgium.
Objective:
Helicobacter pylori and human immunodeficiency virus (HIV) are both pandemic infections with variable geographic prevalence rates. H. pylori-HIV co-infection at the regional and sub-regional levels with a perspective on gastric cancer incidence is discussed.
Design:
Based on PRISMA guidelines, national data for H. pylori, HIV, and H. pylori-HIV co-infection were collected for the general population through December 2019. Joint temporal and geographical data for H. pylori and HIV infections in 48 countries were available and used to generate H. pylori-HIV co-infection estimates by cross-sectional analysis. These data were compared with gastric carcinoma statistics for the same countries.
Results:
The estimated global prevalence rate of H. pylori-HIV co-infection was 1.7 per 1000 people, representing 12.6 million people. Prevalence according to region was, in decreasing order, sub-Saharan Africa 21.9‱, Eastern Europe/Central Asia 4.3‱, Latin America/Caribbean 2.0 ‱, North America/Western/Southern/Northern Europe 1.1‱, Asia/Pacific 0.8‱, and North Africa/Middle East 0.1 ‱. The incidence and mortality rates for gastric carcinoma were higher in East/Pacific Asia, Southern/Andean Latin America, and Eastern Europe regions, and the incidence appeared to be 1.8-fold greater in H. pylori-HIV-infected people in East Asia.
Conclusions:
The population at risk of H. pylori-HIV co-infection is estimated to be 12.6 million people (2015 reference year). The heterogeneity of H. pylori-HIV co-infection across regions and sub-regions does not show a clear association with gastric carcinoma. Other methodological approaches with analytical studies (cohort, case-control) are required to measure the potential effect of H. pylori infection and its treatment on the incidence of gastric carcinoma in the large HIV-H. pylori-positive cohort.
More Related Videos
Related Concept Videos
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...